BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15266326)

  • 1. Natural Baicalein-Rich Fraction as Radiosensitizer in Combination with Bismuth Oxide Nanoparticles and Cisplatin for Clinical Radiotherapy.
    Sisin NNT; Mat NFC; Rashid RA; Dollah N; Razak KA; Geso M; Algethami M; Rahman WN
    Int J Nanomedicine; 2022; 17():3853-3874. PubMed ID: 36081572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine containing porous organosilica nanoparticles trigger tumor spheroids destruction upon monochromatic X-ray irradiation: DNA breaks and K-edge energy X-ray.
    Higashi Y; Matsumoto K; Saitoh H; Shiro A; Ma Y; Laird M; Chinnathambi S; Birault A; Doan TLH; Yasuda R; Tajima T; Kawachi T; Tamanoi F
    Sci Rep; 2021 Jul; 11(1):14192. PubMed ID: 34262055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in the use of Auger electrons in science and medicine during the period 2015-2019.
    Howell RW
    Int J Radiat Biol; 2023; 99(1):2-27. PubMed ID: 33021416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine nanoparticle radiotherapy of human breast cancer growing in the brains of athymic mice.
    Hainfeld JF; Ridwan SM; Stanishevskiy FY; Smilowitz HM
    Sci Rep; 2020 Sep; 10(1):15627. PubMed ID: 32973267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution modeling of nanoparticles for brachytherapy of human eye tumor.
    Masoudi SF; Daryabari FS; Rasouli FS
    EJNMMI Phys; 2020 Aug; 7(1):53. PubMed ID: 32816237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy.
    Sisin NNT; Abdul Razak K; Zainal Abidin S; Che Mat NF; Abdullah R; Ab Rashid R; Khairil Anuar MA; Mohd Zainudin NH; Tagiling N; Mat Nawi N; Rahman WN
    Int J Nanomedicine; 2019; 14():9941-9954. PubMed ID: 31908451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: Implications for the Auger therapy.
    Matsumoto K; Saitoh H; Doan TLH; Shiro A; Nakai K; Komatsu A; Tsujimoto M; Yasuda R; Kawachi T; Tajima T; Tamanoi F
    Sci Rep; 2019 Sep; 9(1):13275. PubMed ID: 31570738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. W-doped TiO
    Gao K; Tu W; Yu X; Ahmad F; Zhang X; Wu W; An X; Chen X; Li W
    Theranostics; 2019; 9(18):5214-5226. PubMed ID: 31410211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Effect of Iodine Contrast Media, Cisplatin and External Beam Radiotherapy on Anaplastic Thyroid Cancer Cells.
    Nadi S; Shabestani Monfared A; Zabihi E; Mahmoudzadeh A; Eyvazzadeh N; Tahamtan R
    J Biomed Phys Eng; 2019 Apr; 9(2):217-226. PubMed ID: 31214527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostics based on AIEgens.
    Wang D; Lee MMS; Xu W; Kwok RTK; Lam JWY; Tang BZ
    Theranostics; 2018; 8(18):4925-4956. PubMed ID: 30429878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of dose enhancement caused by AuNPs with Xoft
    Shahhoseini E; Ramachandran P; Patterson WR; Geso M
    Int J Nanomedicine; 2018; 13():5733-5741. PubMed ID: 30310276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced radiation dose and DNA damage associated with iodinated contrast media in diagnostic X-ray imaging.
    Harbron R; Ainsbury EA; Bouffler SD; Tanner RJ; Eakins JS; Pearce MS
    Br J Radiol; 2017 Nov; 90(1079):20170028. PubMed ID: 28830201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage.
    Bayart E; Pouzoulet F; Calmels L; Dadoun J; Allot F; Plagnard J; Ravanat JL; Bridier A; Denozière M; Bourhis J; Deutsch E
    PLoS One; 2017; 12(1):e0168395. PubMed ID: 28045991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal energy for cell radiosensitivity enhancement by gold nanoparticles using synchrotron-based monoenergetic photon beams.
    Rahman WN; Corde S; Yagi N; Abdul Aziz SA; Annabell N; Geso M
    Int J Nanomedicine; 2014; 9():2459-67. PubMed ID: 24899803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute perfusion measurements and associated iodinated contrast agent time course in brain metastasis: a study for contrast-enhanced radiotherapy.
    Obeid L; Deman P; Tessier A; Balosso J; Estève F; Adam JF
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):638-45. PubMed ID: 24447951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral delivery of carboplatin in combination with either 6 MV photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma.
    Bobyk L; Edouard M; Deman P; Rousseau J; Adam JF; Ravanat JL; Estève F; Balosso J; Barth RF; Elleaume H
    J Exp Clin Cancer Res; 2012 Sep; 31(1):78. PubMed ID: 22992374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles.
    Li X; Zhou H; Yang L; Du G; Pai-Panandiker AS; Huang X; Yan B
    Biomaterials; 2011 Apr; 32(10):2540-5. PubMed ID: 21232787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auger processes in the 21st century.
    Howell RW
    Int J Radiat Biol; 2008 Dec; 84(12):959-75. PubMed ID: 19061120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds.
    Corde S; Joubert A; Adam JF; Charvet AM; Le Bas JF; Estève F; Elleaume H; Balosso J
    Br J Cancer; 2004 Aug; 91(3):544-51. PubMed ID: 15266326
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.